Cardiovascular Drugs Practice Questions

Q: Which of the following methods can reduce flushing caused by niacin?

All of the options. ***All of the options*** - **All three methods** (tachyphylaxis, laropiprant, and premedication with aspirin) are effective strategies for reducing niacin-induced flushing. - This demonstrates that multiple pharmacological and physiological approaches can mitigate this common side effect of niacin therapy. **Why each method works:** **Tachyphylaxis:** - Refers to the rapid decrease in response to a drug after repeated administration - With continued niacin use, tolerance develops and flushing intensity decreases over time - This is a natural adaptive response, though not an immediate solution for initial flushing episodes **Laropiprant:** - A selective antagonist of the **prostaglandin D2 receptor 1 (DP1)** - Specifically developed to reduce niacin-induced flushing by blocking prostaglandin D2-mediated vasodilation - Was marketed in combination with niacin (though later withdrawn due to other safety concerns) **Premedication with aspirin:** - **Aspirin** or other NSAIDs taken approximately 30 minutes before niacin administration - Reduces flushing by inhibiting **prostaglandin synthesis**, particularly prostaglandin D2 - Prostaglandins are key mediators of the cutaneous vasodilation that causes flushing

Q: Which of the following medications is primarily used to decrease serum triglycerides?

Fibrates. ***Fibrates*** - Fibrates, such as **gemfibrozil** and **fenofibrate**, are primarily used to activate **PPAR-alpha**, leading to increased lipoprotein lipase activity and reduced hepatic triglyceride synthesis. - This effectively lowers **serum triglyceride levels** by 20-50% and can also increase HDL cholesterol. *Statin* - Statins primarily inhibit **HMG-CoA reductase**, the rate-limiting enzyme in cholesterol synthesis, which makes them highly effective at lowering **LDL cholesterol**. - While they can cause a modest reduction in triglycerides (10-30%), this is not their primary mechanism or indication. *Ezetimibe* - Ezetimibe works by inhibiting the absorption of **cholesterol** at the brush border of the small intestine, thereby lowering **LDL cholesterol**. - It has minimal effect on **triglyceride levels** and is not indicated for primary triglyceride reduction. *Niacin* - Niacin, or **nicotinic acid**, reduces the liver's production of VLDL (which contains triglycerides) and LDL, and also increases HDL cholesterol. - While it can significantly lower triglycerides, its use is often limited by bothersome side effects such as **flushing** and itchiness, making fibrates generally preferred for primary triglyceride lowering due to better tolerability.

Q: Which of the following adverse effects of ACE inhibitors is primarily due to the inhibition of aldosterone secretion?

Hyperkalemia. ***Hyperkalemia*** - **Angiotensin II** stimulates aldosterone secretion, and **ACE inhibitors** block angiotensin II formation, leading to reduced aldosterone. - **Aldosterone** promotes sodium reabsorption and potassium excretion in the renal tubules, so its reduction causes **potassium retention** and **hyperkalemia**. - This is the primary adverse effect mediated through the **aldosterone pathway**. *Respiratory tract irritation* - This is primarily due to the accumulation of **bradykinin** and **substance P** in the airways, not due to the inhibition of aldosterone. - ACE is responsible for bradykinin breakdown, so its inhibition leads to **bradykinin accumulation** causing cough. *Facial swelling* - This is a symptom of **angioedema**, which is related to the accumulation of **bradykinin** due to ACE inhibition, not due to aldosterone inhibition. - Bradykinin causes **vasodilation** and increased vascular permeability. *Hypotension* - While hypotension can occur with ACE inhibitors, it is primarily due to reduced formation of the potent vasoconstrictor **angiotensin II**, causing **decreased systemic vascular resistance**. - This is NOT primarily mediated through the aldosterone pathway, but through direct vascular effects.

Q: Which class of antihypertensive drugs is known to cause erectile dysfunction?

Beta-blockers. ***Beta-blockers*** - **Beta-blockers** are the antihypertensive class most commonly associated with **erectile dysfunction** - Mechanism: Reduced cardiac output, decreased peripheral blood flow, central nervous system effects reducing libido, and blockade of β2-mediated vasodilation - **Non-selective beta-blockers** (propranolol, nadolol) have higher incidence of ED compared to selective β1-blockers (metoprolol, atenolol) - Newer vasodilating beta-blockers (nebivolol, carvedilol) have lower risk of sexual dysfunction *Calcium channel blockers* - Generally have **neutral or minimal effect** on erectile function - May even improve ED in some patients due to **vasodilatory properties** - Side effects include peripheral edema and headache, but not sexual dysfunction *ACE inhibitors* - Associated with **lower risk of erectile dysfunction** compared to other antihypertensives - May have neutral or even protective effects on sexual function - Preferred choice for hypertensive patients with existing sexual dysfunction concerns - Common side effects: dry cough and angioedema (not related to sexual function) *AT1 receptor antagonists* - **ARBs have neutral to potentially beneficial effects** on sexual function - Considered an excellent alternative for patients experiencing sexual side effects with other antihypertensive medications - Some studies suggest they may improve erectile function in hypertensive patients

Q: Which of the following is a characteristic of simvastatin?

Derived from fungal metabolite. ***Derived from fungal metabolite*** - **Simvastatin** and lovastatin are **naturally-derived statins** obtained from **fungal metabolites** (*Aspergillus terreus*), distinguishing them from synthetic statins like atorvastatin, rosuvastatin, and pravastatin [2]. - This is the **most distinguishing characteristic** for classification purposes, as it represents the drug's origin and places it in a specific subclass of HMG-CoA reductase inhibitors. - The discovery of fungal-derived statins led to the development of the entire statin drug class. *Prodrug requiring hepatic activation* - While **simvastatin** is a **lactone prodrug** requiring hepatic hydrolysis to its active beta-hydroxy acid form, this is a pharmacokinetic property shared with lovastatin [1]. - This is a characteristic but not the most distinguishing feature for classification. *Specific CYP3A4 substrate with high interaction potential* - **Simvastatin** is extensively metabolized by **CYP3A4**, leading to significant drug-drug interactions with CYP3A4 inhibitors (e.g., ketoconazole, erythromycin, grapefruit juice). - While clinically important, many drugs are CYP3A4 substrates, making this less distinctive as a defining characteristic. *Short half-life requiring evening dosing* - **Simvastatin** has a **short half-life** (2-3 hours) and is preferably administered in the evening because cholesterol synthesis is highest at night. - This is a dosing consideration based on pharmacokinetics rather than a fundamental distinguishing characteristic of the drug's identity.

Q: Which of the following is non-selective 3rd generation Beta blocker ?

Carvedilol. ***Carvedilol*** - **Carvedilol** is a **non-selective beta-adrenergic antagonist** (blocks both β1 and β2 receptors) with **additional α1-adrenergic blocking activity**, making it a true **3rd generation beta-blocker**. - The α1-blockade provides **vasodilatory properties**, reducing peripheral vascular resistance and improving hemodynamics. - It has favorable effects on lipid metabolism and insulin sensitivity, making it particularly useful in heart failure and hypertension. - Its non-selective beta-blockade combined with vasodilation distinguishes it from selective 3rd generation agents. *Betaxolol* - **Betaxolol** is a **selective β1-adrenergic antagonist** without vasodilatory properties. - Classified as a **2nd generation beta-blocker** due to its cardioselectivity. - Primarily used in glaucoma and hypertension but lacks the non-selective profile and additional mechanisms of 3rd generation agents. *Celiprolol* - **Celiprolol** is a **β1-selective antagonist** with **β2-agonistic effects** providing vasodilation. - While classified as 3rd generation due to vasodilatory properties, it is **selective for β1**, not non-selective. - Its β2-agonism causes peripheral vasodilation but maintains β1-selectivity. *Nebivolol* - **Nebivolol** is a highly **selective β1-adrenergic antagonist** with **vasodilatory effects via nitric oxide (NO) release**. - Classified as 3rd generation due to NO-mediated vasodilation, but it is **β1-selective**, not non-selective. - The combination of high β1-selectivity and endothelial-mediated vasodilation makes it unique among 3rd generation agents.

Q: Which of the following is not a known side effect of amiodarone?

Hyperglycemia. ***Hyperglycemia*** - **Hyperglycemia** is generally **not recognized** as a direct or common side effect of amiodarone. - Amiodarone's primary action is on cardiac ion channels, and its metabolic effects typically involve thyroid function, not glucose regulation. *Hyperthyroidism* - Amiodarone contains **iodine**, which can induce **thyroid dysfunction**, including both hypo- and hyperthyroidism. - **Amiodarone-induced hyperthyroidism (AIH)** can occur due to increased thyroid hormone synthesis or destructive thyroiditis. *Peripheral neuropathy* - **Neurological side effects**, including **peripheral neuropathy**, are known to occur with chronic amiodarone use. - Symptoms often include **paresthesias**, weakness, and sensory loss in the extremities. *Skin discoloration* - Prolonged use of amiodarone can lead to **bluish-gray skin discoloration**, particularly in sun-exposed areas. - This is due to the **accumulation of amiodarone** and its metabolites in the skin.

Q: Beta-blockers should be used with caution in patients with?

Conduction defect. ***Conduction defect*** - Beta-blockers **slow heart rate** and **decrease AV nodal conduction**, which can worsen pre-existing conduction defects like **AV block** or **sick sinus syndrome**. - Their use can lead to **symptomatic bradycardia** or complete heart block in susceptible individuals. - This represents a **strong relative contraindication** requiring significant caution. *Hypertension* - Beta-blockers are a **first-line treatment for hypertension**, effectively lowering blood pressure by reducing cardiac output and renin release. - They are generally **well-tolerated** and beneficial in most hypertensive patients. *Glaucoma* - Topical beta-blockers, such as **timolol**, are a common treatment for open-angle glaucoma as they **reduce aqueous humor production**, thereby lowering intraocular pressure. - Systemic use of beta-blockers does not typically worsen glaucoma and may even offer some benefit. *CHF* - While certain beta-blockers (**carvedilol, metoprolol succinate, bisoprolol**) are now proven beneficial in **chronic heart failure with reduced ejection fraction (HFrEF)**, they do require careful use. - They must be **initiated at low doses and carefully titrated** to avoid acute decompensation, and are **contraindicated in acute decompensated heart failure**. - However, **conduction defects** represent a **stronger contraindication** where beta-blockers can cause life-threatening bradycardia or complete heart block, making it the best answer for conditions requiring the most caution.

Q: Which ACE inhibitor is safe in renal failure?

Benazepril. ***Benazepril*** - Among the listed ACE inhibitors, benazepril has the **most favorable excretion profile** in renal failure with approximately **50% renal and 50% hepatic elimination** (dual excretion pathway). - This balanced elimination reduces the risk of drug accumulation compared to predominantly renally excreted ACE inhibitors. - While dose adjustment may still be needed in **severe renal impairment**, benazepril is considered the **safest option among those listed** for patients with renal dysfunction. - **Note:** Fosinopril (not listed here) has true 50/50 dual elimination and requires no dose adjustment in renal failure, making it the ideal choice in clinical practice. *Captopril* - This ACE inhibitor undergoes predominantly **renal excretion (95%)** as unchanged drug and metabolites. - Requires significant **dose reduction** in renal failure to prevent accumulation and adverse effects including **hyperkalemia** and **hypotension**. - Less safe than benazepril in renal impairment due to heavy dependence on renal elimination. *Enalapril* - Enalapril is a prodrug converted to **enalaprilat**, with approximately **90% renal excretion**. - Dose adjustment is mandatory based on **creatinine clearance** in patients with renal failure. - Higher risk of accumulation and toxicity compared to dual-elimination ACE inhibitors like benazepril.

Q: Fenoldopam is used in the management of?

Hypertensive emergencies. ***Hypertensive emergencies*** - **Fenoldopam** is a **dopamine D1 receptor agonist** that causes rapid, dose-dependent peripheral vasodilation and increased renal blood flow, making it suitable for acute blood pressure reduction during hypertensive emergencies. - Its **rapid onset** and short half-life allow for precise control of blood pressure, and its **benefit** in preserving or improving renal function is particularly beneficial in patients with renal impairment. *Congestive heart failure* - While fenoldopam can increase renal blood flow, it is not a primary treatment for **congestive heart failure (CHF)** and is not typically used for its management. - Other drug classes, such as **diuretics**, **ACE inhibitors**, and **beta-blockers**, are the mainstays of CHF treatment. *Migraine prophylaxis* - Fenoldopam has **no role** in the prevention or acute treatment of migraines. - **Beta-blockers**, **calcium channel blockers**, and certain **antidepressants** are commonly used for migraine prophylaxis. *Tachyarrhythmias* - Fenoldopam **does not have antiarrhythmic properties** and is not indicated for the treatment of tachyarrhythmias. - **Beta-blockers**, **calcium channel blockers**, and specific **antiarrhythmic drugs** are used to manage tachyarrhythmias.

Question 1

Which of the following methods can reduce flushing caused by niacin?

Accepted Answer

All of the options

Answer

Tachyphylaxis

Answer

Laropiprant

Answer

Premedication with aspirin

Question 2

Which of the following medications is primarily used to decrease serum triglycerides?

Accepted Answer

Fibrates

Answer

Ezetimibe

Answer

Niacin

Answer

Statin

Question 3

Which of the following adverse effects of ACE inhibitors is primarily due to the inhibition of aldosterone secretion?

Accepted Answer

Hyperkalemia

Answer

Respiratory tract irritation

Answer

Facial swelling

Answer

Hypotension

Question 4

Which class of antihypertensive drugs is known to cause erectile dysfunction?

Accepted Answer

Beta-blockers

Answer

Calcium channel blocker

Answer

ACE inhibitors

Answer

AT1 receptor antagonists

Question 5

Which of the following is a characteristic of simvastatin?

Accepted Answer

Derived from fungal metabolite

Answer

Specific CYP3A4 substrate with high interaction potential

Answer

Prodrug requiring hepatic activation

Answer

Short half-life requiring evening dosing

Question 6

Which of the following is non-selective 3rd generation Beta blocker ?

Accepted Answer

Carvedilol

Answer

Betaxolol

Answer

Celiprolol

Answer

Nebivolol

Question 7

Which of the following is not a known side effect of amiodarone?

Accepted Answer

Hyperglycemia

Answer

Peripheral neuropathy

Answer

Hyperthyroidism

Answer

Skin discoloration

Question 8

Beta-blockers should be used with caution in patients with?

Accepted Answer

Conduction defect

Answer

Hypertension

Answer

CHF

Answer

Glaucoma

Question 9

Which ACE inhibitor is safe in renal failure?

Accepted Answer

Benazepril

Answer

Captopril

Answer

Enalapril

Answer

None of the options

Question 10

Fenoldopam is used in the management of?

Accepted Answer

Hypertensive emergencies

Answer

Congestive heart failure

Answer

Migraine prophylaxis

Answer

Tachyarrhythmias

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?